RS

Robert Sikorski

FT Five Prime Therapeutics: 8 patents #12 of 117Top 15%
BS Bristol-Myers Squibb: 5 patents #1,010 of 3,969Top 30%
📍 South San Francisco, CA: #215 of 1,066 inventorsTop 25%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #550,494 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11566076 Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers Brian Wong, Julie Hambleton, Emma Masteller, Kevin Hestir, David Bellovin +1 more 2023-01-31
11447553 FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatment Kristen Pierce, Janine Powers, Servando Palencia, Majid Ghoddusi, Kartik KRISHNAN 2022-09-20
11421034 Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer Katherine E. Lewis, Serena Kimi Perna, Michael Carleton, Ke Xu, Penny Phillips +8 more 2022-08-23
10975153 Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Julie Hambleton, Emma Masteller, James Zanghi, Hong Xiang 2021-04-13
10730949 Method of treating PVNS with anti-CSF1R antibodies Julie Hambleton, Nilacantan Sankar 2020-08-04
10618967 Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Brian Wong, Julie Hambleton, Emma Masteller, Kevin Hestir, David Bellovin +1 more 2020-04-14
10221244 Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Brian Wong, Julie Hambleton, Emma Masteller, Kevin Hestir, David Bellovin +1 more 2019-03-05
10040858 Anti-CSF1R antibodies for treating PVNS Julie Hambleton, Nilacantan Sankar 2018-08-07
9765147 Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer Brian Wong, Julie Hambleton, Emma Masteller, Kevin Hestir, David Bellovin +1 more 2017-09-19